Amgen Deferred Taxes decreased by 1.6% to $1.34B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 11.0%, from $1.51B to $1.34B. Over 3 years (FY 2022 to FY 2025), Deferred Taxes shows an upward trend with a 398.9% CAGR.
An increase suggests the company is deferring tax payments, which can improve current cash flow, while a decrease indicates the settlement of these deferred obligations.
This represents the amount of income taxes payable in future periods as a result of temporary differences between the ca...
Standard across all industries; levels are driven by capital expenditure cycles and depreciation methods.
other_deferred_income_tax_liabilities_net| Q4 '22 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $11.00M | $2.35B | $1.86B | $1.78B | $1.71B | $1.62B | $1.51B | $1.39B | $1.46B | $1.37B | $1.34B |
| QoQ Change | — | >999% | -20.9% | -4.4% | -3.9% | -5.6% | -6.6% | -8.2% | +5.2% | -6.3% | -1.6% |
| YoY Change | — | >999% | — | — | — | -31.4% | -18.9% | -22.1% | -14.8% | -15.5% | -11.0% |